399 A phase II study of nivolumab, ipilimumab, plus androgen receptor blockade with bicalutamide to enhance thymic T-cell production and immunotherapy response in metastatic breast cancer

David Page; Krystle Collins; Brie Chun; Zhaoyu Sun; Yoshinobu Koguchi; William Redmond; Maritza Martel; Yaping Wu; Nicole Moxon; Staci Mellinger; Walter Urba; Ayca Gucalp; Tiffany Traina

doi:10.1136/jitc-2021-SITC2021.399

Article info

Regular and Young Investigator Award Abstracts

Clinical Trials In Progress

399 A phase II study of nivolumab, ipilimumab, plus androgen receptor blockade with bicalutamide to enhance thymic T-cell production and immunotherapy response in metastatic breast cancer

Free

Authors

David Page Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, USA PubMed articles Google scholar articles
Krystle Collins Providence Cancer Institute, Portland, OR, USA PubMed articles Google scholar articles
Brie Chun Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, USA PubMed articles Google scholar articles
Zhaoyu Sun Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, USA PubMed articles Google scholar articles
Yoshinobu Koguchi Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, USA PubMed articles Google scholar articles
William Redmond Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, USA PubMed articles Google scholar articles
Maritza Martel Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, USA PubMed articles Google scholar articles
Yaping Wu Earle A. Chiles Research Institute, Prov, Portland, OR, USA PubMed articles Google scholar articles
Nicole Moxon Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, USA PubMed articles Google scholar articles
Staci Mellinger Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, USA PubMed articles Google scholar articles
Walter Urba Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, USA PubMed articles Google scholar articles
Ayca Gucalp Memorial Sloan Cancer Center, New York, NY, USA PubMed articles Google scholar articles
Tiffany Traina Memorial Sloan Kettering Cancer Center, New York, NY, USA PubMed articles Google scholar articles

Citation

Page D, Collins K, Chun B, et al

399 A phase II study of nivolumab, ipilimumab, plus androgen receptor blockade with bicalutamide to enhance thymic T-cell production and immunotherapy response in metastatic breast cancer

Journal for ImmunoTherapy of Cancer 2021;9:doi: 10.1136/jitc-2021-SITC2021.399

Publication history

First published November 10, 2021.

Online issue publication

November 10, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password